The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease

Neurobiology of Disease

Volumn 69, Issue , 2014, Pages 180-191

  Hwang, Ran Der ^a   Wiemerslage, Lyle ^b   LaBreck, Christopher J ^a   Khan, Munzareen ^a   Kannan, Kavitha ^a   Wang, Xinglong ^c   Zhu, Xiongwei ^c   Lee, Daewoo ^b   Fridell, Yih Woei C ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b OHIO UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRP1 PROTEIN; ROTENONE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; CYCLIC AMP; CYTOSKELETON PROTEIN; DRP1 PROTEIN, DROSOPHILA; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUSION; CELL LEVEL; CELL LOSS; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; IN VIVO STUDY; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DROSOPHILA; DRUG EFFECTS; EYE; FEMALE; GENETICS; HUMAN; INTRACELLULAR SPACE; METABOLISM; MITOCHONDRIAL DYNAMICS; PARKINSONISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSKELETAL PROTEINS; DOPAMINERGIC NEURONS; DROSOPHILA; EYE; FEMALE; GTP-BINDING PROTEINS; HUMANS; INTRACELLULAR SPACE; ION CHANNELS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; PARKINSONIAN DISORDERS; PHENOTYPE; ROTENONE;

EID: 84902658671     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.05.032     Document Type: Article

References (66)

1. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26:211-215.
2. Andrews Z.B., Diano S., Horvath T.L. Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nat. Rev. Neurosci. 2005, 6:829-840.
3. Andrews Z.B., Horvath B., Barnstable C.J., Elsworth J., Yang L., Beal M.F., Roth R.H., Matthews R.T., Horvath T.L. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25:184-191.
4. Arnold B., Cassady S.J., VanLaar V.S., Berman S.B. Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model. Neurobiol. Dis. 2011, 41:189-200.
5. Arnoult D. Mitochondrial fragmentation in apoptosis. Trends Cell Biol. 2007, 17:6-12.
6. Azzu V., Jastroch M., Divakaruni A.S., Brand M.D. The regulation and turnover of mitochondrial uncoupling proteins. Biochim. Biophys. Acta 2010, 1797:785-791.
7. Banerjee R., Starkov A.A., Beal M.F., Thomas B. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim. Biophys. Acta 2009, 1792:651-663.
8. Barkus R.V., Klyachko O., Horiuchi D., Dickson B.J., Saxton W.M. Identification of an axonal kinesin-3 motor for fast anterograde vesicle transport that facilitates retrograde transport of neuropeptides. Mol. Biol. Cell 2008, 19:274-283.
9. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., Graber S., Kovacs I., Lee W.D., Waggoner J., Cui J., et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006, 25:3900-3911.
10. Berman S.B., Chen Y.B., Qi B., McCaffery J.M., Rucker E.B., Goebbels S., Nave K.A., Arnold B.A., Jonas E.A., Pineda F.J., et al. Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J. Cell Biol. 2009, 184:707-719.
11. Cannon J.R., Tapias V., Na H.M., Honick A.S., Drolet R.E., Greenamyre J.T. A highly reproducible rotenone model of Parkinson's disease. Neurobiol. Dis. 2009, 34:279-290.
12. Cassidy-Stone A., Chipuk J.E., Ingerman E., Song C., Yoo C., Kuwana T., Kurth M.J., Shaw J.T., Hinshaw J.E., Green D.R., et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell 2008, 14:193-204.
13. Cereghetti G.M., Stangherlin A., Martins de Brito O., Chang C.R., Blackstone C., Bernardi P., Scorrano L. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15803-15808.
14. Chan D.C. Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 2006, 22:79-99.
15. Chang C.R., Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J. Biol. Chem. 2007, 282:21583-21587.
16. Choi W.S., Kruse S.E., Palmiter R.D., Xia Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15136-15141.
17. Choi W.S., Palmiter R.D., Xia Z. Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model. J. Cell Biol. 2011, 192:873-882.
18. Chu C.T., Ji J., Dagda R.K., Jiang J.F., Tyurina Y.Y., Kapralov A.A., Tyurin V.A., Yanamala N., Shrivastava I.H., Mohammadyani D., et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 2013, 15:1197-1205.
19. Conti B., Sugama S., Lucero J., Winsky-Sommerer R., Wirz S.A., Maher P., Andrews Z., Barr A.M., Morale M.C., Paneda C., et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J. Neurochem. 2005, 93:493-501.
20. Coulom H., Birman S. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J. Neurosci. Off. J. Soc. Neurosci. 2004, 24:10993-10998.
21. Cribbs J.T., Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007, 8:939-944.
22. Dagda R.K., Gusdon A.M., Pien I., Strack S., Green S., Li C., Van Houten B., Cherra S.J., Chu C.T. Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ. 2011, 18:1914-1923.
23. Delettre C., Lenaers G., Griffoin J.M., Gigarel N., Lorenzo C., Belenguer P., Pelloquin L., Grosgeorge J., Turc-Carel C., Perret E., et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000, 26:207-210.
24. Deng M., He W., Tan Y., Han H., Hu X., Xia K., Zhang Z., Yan R. Increased expression of reticulon 3 in neurons leads to reduced axonal transport of beta site amyloid precursor protein-cleaving enzyme 1. J. Biol. Chem. 2013, 288:30236-30245.
25. Fleming S.M., Zhu C., Fernagut P.O., Mehta A., DiCarlo C.D., Seaman R.L., Chesselet M.F. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp. Neurol. 2004, 187:418-429.
26. Frank S., Gaume B., Bergmann-Leitner E.S., Leitner W.W., Robert E.G., Catez F., Smith C.L., Youle R.J. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 2001, 1:515-525.
27. Fridell Y.W., Hoh M., Kreneisz O., Hosier S., Chang C., Scantling D., Mulkey D.K., Helfand S.L. Increased uncoupling protein (UCP) activity in Drosophila insulin-producing neurons attenuates insulin signaling and extends lifespan. Aging (Albany NY) 2009, 1:699-713.
28. Friggi-Grelin F., Coulom H., Meller M., Gomez D., Hirsh J., Birman S. Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. J. Neurobiol. 2003, 54:618-627.
29. Galluzzi L., Kepp O., Kroemer G. Mitochondrial dynamics: a strategy for avoiding autophagy. Curr. Biol. 2011, 21:R478-R480.
30. Gao H.M., Hong J.S., Zhang W., Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. Off. J. Soc. Neurosci. 2002, 22:782-790.
31. Gomes L.C., Di Benedetto G., Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 2011, 13:589-598.
32. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4078-4083.
33. Hisahara S., Shimohama S. Toxin-induced and genetic animal models of Parkinson's disease. Park. Dis. 2010, 2011:951709.
34. Ho P.W., Ho J.W., Liu H.F., So D.H., Tse Z.H., Chan K.H., Ramsden D.B., Ho S.L. Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease. Transl. Neurodegener. 2012, 1:3.
35. Hoglinger G.U., Feger J., Prigent A., Michel P.P., Parain K., Champy P., Ruberg M., Oertel W.H., Hirsch E.C. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 2003, 84:491-502.
36. Islam R., Yang L., Sah M., Kannan K., Anamani D., Vijayan C., Kwok J., Cantino M.E., Beal M.F., Fridell Y.W. A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model. Neurobiol. Dis. 2012, 46:137-146.
37. Karbowski M., Arnoult D., Chen H., Chan D.C., Smith C.L., Youle R.J. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J. Cell Biol. 2004, 164:493-499.
38. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
39. Liou H.H., Tsai M.C., Chen C.J., Jeng J.S., Chang Y.C., Chen S.Y., Chen R.C. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997, 48:1583-1588.
40. Lochner A., Moolman J.A. The many faces of H89: a review. Cardiovasc. Drug Rev. 2006, 24:261-274.
41. Marella M., Seo B.B., Nakamaru-Ogiso E., Greenamyre J.T., Matsuno-Yagi A., Yagi T. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease. PLoS ONE 2008, 3:e1433.
42. Merrill R.A., Dagda R.K., Dickey A.S., Cribbs J.T., Green S.H., Usachev Y.M., Strack S. Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1. PLoS Biol. 2011, 9:e1000612.
43. Misko A., Jiang S., Wegorzewska I., Milbrandt J., Baloh R.H. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30:4232-4240.
44. Neretti N., Wang P.Y., Brodsky A.S., Nyguyen H.H., White K.P., Rogina B., Helfand S.L. Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2277-2282.
45. Ng C.H., Guan M.S., Koh C., Ouyang X., Yu F., Tan E.K., O'Neill S.P., Zhang X., Chung J., Lim K.L. AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32:14311-14317.
46. Panov A., Dikalov S., Shalbuyeva N., Taylor G., Sherer T., Greenamyre J.T. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J. Biol. Chem. 2005, 280:42026-42035.
47. Park S.S., Lee D. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures. Eur. J. Neurosci. 2006, 23:2908-2914.
48. Park S.S., Schulz E.M., Lee D. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein. Eur. J. Neurosci. 2007, 26:3104-3112.
49. Park J., Lee G., Chung J. The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem. Biophys. Res. Commun. 2009, 378:518-523.
50. Perier C., Bove J., Vila M., Przedborski S. The rotenone model of Parkinson's disease. Trends Neurosci. 2003, 26:345-346.
51. Pham A.H., Meng S., Chu Q.N., Chan D.C. Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum. Mol. Genet. 2012, 21:4817-4826.
52. Poole A.C., Thomas R.E., Andrews L.A., McBride H.M., Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1638-1643.
53. Sanders L.H., Timothy Greenamyre J. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic. Biol. Med. 2013, 62:111-120.
54. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23:10756-10764.
55. Sherer T.B., Betarbet R., Kim J.H., Greenamyre J.T. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci. Lett. 2003, 341:87-90.
56. Twig G., Shirihai O.S. The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal. 2011, 14:1939-1951.
57. Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 2008, 1777:1092-1097.
58. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995, 184:39-51.
59. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19318-19323.
60. Wang X., Su B., Liu W., He X., Gao Y., Castellani R.J., Perry G., Smith M.A., Zhu X. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease. Aging Cell 2011, 10:807-823.
61. Whitworth A.J., Lee J.R., Ho V.M., Flick R., Chowdhury R., McQuibban G.A. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin. Dis. Model. Mech. 2008, 1:168-174. (discussion 173).
62. Yadava N., Nicholls D.G. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J. Neurosci. Off. J. Soc. Neurosci. 2007, 27:7310-7317.
63. Yang Y., Ouyang Y., Yang L., Beal M.F., McQuibban A., Vogel H., Lu B. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7070-7075.
64. Yu T., Fox R.J., Burwell L.S., Yoon Y. Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1. J. Cell Sci. 2005, 118:4141-4151.
65. Zhu C., Vourc'h P., Fernagut P.O., Fleming S.M., Lacan S., Dicarlo C.D., Seaman R.L., Chesselet M.F. Variable effects of chronic subcutaneous administration of rotenone on striatal histology. J. Comp. Neurol. 2004, 478:418-426.
66. Ziviani E., Tao R.N., Whitworth A.J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5018-5023.